Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | KDM6B | O15054 | 1/20 | 0.41 |
| ▸ | KDM5C | P41229 | 1/20 | 0.41 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.41 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.41 |
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 6/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.36 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.34 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17796306 | 1.00 | ALDH1A1 (0.45) | ALDH1A1ADRA2AADRA1AEGLN1MAPT | |
| SCHEMBL25585247 | 1.00 | ALDH1A1 (0.45) | ALDH1A1ADRA2AADRA1AEGLN1MAPT | |
| SCHEMBL17796302 | 1.00 | ALDH1A1 (0.45) | ALDH1A1ADRA2AADRA1AEGLN1MAPT | |
| SCHEMBL28323524 | 1.00 | ALDH1A1 (0.45) | ALDH1A1ADRA2AADRA1AEGLN1MAPT | |
| SCHEMBL818345 | 1.00 | ALDH1A1 (0.45) | ALDH1A1ADRA2AADRA1AEGLN1MAPT | |
| SCHEMBL1264931 | 1.00 | ALDH1A1 (0.45) | ALDH1A1ADRA2AADRA1AEGLN1MAPT | |
| SCHEMBL28946417 | 1.00 | ALDH1A1 (0.45) | ALDH1A1ADRA2AADRA1AEGLN1MAPT | |
| SCHEMBL4477766 | 0.98 | ALDH1A1 (0.44) | ALDH1A1ADRA2AADRA1AEGLN1MAPT | |
| SCHEMBL4467145 | 0.98 | ALDH1A1 (0.44) | ALDH1A1ADRA2AADRA1AEGLN1MAPT | |
| SCHEMBL407967 | 0.94 | ALDH1A1 (0.50) | ALDH1A1ADRA2AADRA1AEGLN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130316137-A1 | BRIGHTNESS ENHANCING FILM COMPRISING NANOCOMPOSITE STRUCTURE HAVING IMPROVED CRACK RESISTANCE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-11-28 | — | — | US | claimed |
| US-8530572-B2 | Brightness enhancing film comprising nanocomposite structure having improved crack resistance | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-09-10 | — | — | US | claimed |
| US-20120264899-A1 | BRIGHTNESS ENHANCING FILM COMPRISING NANOCOMPOSITE STRUCTURE HAVING IMPROVED CRACK RESISTANCE | 3M INNOVATIVE PROPERTIES COMPANY | 2012-10-18 | — | — | US | claimed |
| EP-2118149-B1 | BRIGHTNESS ENHANCING FILM COMPRISING NANOCOMPOSITE STRUCTURE HAVING IMPROVED CRACK RESISTANCE | 3M INNOVATIVE PROPERTIES CO (US) | 2012-05-23 | — | — | EP | claimed |
| JP-2010519599-A | — | — | 2010-06-03 | — | — | JP | claimed |
| US-20100033826-A1 | BRIGHTNESS ENHANCING FILM COMPRISING NANOCOMPOSITE STRUCTURE HAVING IMPROVED CRACK RESISTANCE | 3M INNOVATIVE PROPERTIES COMPANY | 2010-02-11 | — | — | US | claimed |
| EP-2118149-A1 | BRIGHTNESS ENHANCING FILM COMPRISING NANOCOMPOSITE STRUCTURE HAVING IMPROVED CRACK RESISTANCE | 3M Innovative Properties Company (US) | 2009-11-18 | — | — | EP | claimed |
| WO-2008121465-A1 | BRIGHTNESS ENHANCING FILM COMPRISING NANOCOMPOSITE STRUCTURE HAVING IMPROVED CRACK RESISTANCE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-10-09 | — | — | WO | claimed |
| US-20230174459-A1 | LIPID CONTAINING FORMULATIONS | ARBUTUS BIOPHARMA CORPORATION (US) | 2023-06-08 | — | — | US | disclosed |
| EP-4106056-A1 | BINDER FOR NONAQUEOUS ELECTROLYTE SECONDARY BATTERIES, ELECTRODE COMPOSITION FOR NONAQUEOUS ELECTROLYTE SECONDARY BATTERIES, ELECTRODE FOR NONAQUEOUS ELECTROLYTE SECONDARY BATTERIES, NONAQUEOUS ELECTROLYTE SECONDARY BATTERY AND METHOD FOR PRODUCING BINDER FOR NONAQUEOUS ELECTROLYTE SECONDARY BATTERIES | Nippon Paper Industries Co., Ltd. (JP) | 2022-12-21 | — | — | EP | disclosed |
| CN-110050039-B | Resin composition | 花王株式会社 | 2022-04-29 | — | — | CN | disclosed |
| CN-107620211-B | Fine cellulose fiber composite | 花王株式会社 | 2021-07-30 | — | — | CN | disclosed |
| US-10961425-B2 | Viscous water-based composition | KAO CORPORATION (JP) | 2021-03-30 | — | — | US | disclosed |
| EP-3275931-B1 | VISCOUS WATER-BASED COMPOSITION | KAO CORP (JP) | 2020-10-14 | — | — | EP | disclosed |
| EP-1939240-B1 | POROUS SHEET | KAO CORP (JP) | 2013-07-31 | — | — | EP | disclosed |
| US-20120046478-A1 | LIPID CONTAINING FORMULATIONS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2012-02-23 | — | — | US | disclosed |
| US-8034376-B2 | Lipid containing formulations | Alnylam Pharamaceticals, Inc. (US) | 2011-10-11 | — | — | US | disclosed |
| US-20110245376-A1 | NANOCALCITE COMPOSITES | 3M INNOVATIVE PROPERTIES COMPANY | 2011-10-06 | — | — | US | disclosed |
| US-20090023673-A1 | LIPID CONTAINING FORMULATIONS | BANK OF AMERICA, N.A. | 2009-01-22 | — | — | US | disclosed |
| EP-1939240-A1 | POROUS SHEET | Kao Corporation (JP) | 2008-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10961425-B2 | Viscous water-based composition | POLL, MYO1G, POLG | ALDH1A1 4758/4885ADRA2A 2754/4885ADRA1A 2172/4885 |
| US-20230174459-A1 | LIPID CONTAINING FORMULATIONS | LIPA, POLRMT, PHOSPHO1 | ALDH1A1 3971/4885ADRA2A 4479/4885ADRA1A 3929/4885 |
| US-20090023673-A1 | LIPID CONTAINING FORMULATIONS | LIPA, POLRMT, PHOSPHO1 | ALDH1A1 3971/4885ADRA2A 4479/4885ADRA1A 3929/4885 |
| US-20120046478-A1 | LIPID CONTAINING FORMULATIONS | LIPA, POLRMT, PHOSPHO1 | ALDH1A1 3971/4885ADRA2A 4479/4885ADRA1A 3929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.